First Report of Sorafenib in Patients With Acute Myeloid Leukemia Harboring Non-Canonical FLT3 Mutations

Overview of attention for article published in Frontiers in oncology, August 2020

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 9 X posts from 8 X users, with an upper bound of 29,399 followers.

RT @doctorpemm: 👉👉👉Hot off the press our group’s latest report ➡️ First Report of #Sorafenib in Patients With Acute Myeloid Leukemia Harbor…

RT @doctorpemm: 👉👉👉Hot off the press our group’s latest report ➡️ First Report of #Sorafenib in Patients With Acute Myeloid Leukemia Harbor…

👉👉👉Hot off the press our group’s latest report ➡️ First Report of #Sorafenib in Patients With Acute Myeloid Leukemia Harboring Non-Canonical #FLT3 Mutations https://t.co/AejF8XKyts | @Daver_Leukemia @allydprice @DrKTakahashi @doctorpemm @LeukemiaMDA #leus

RT @allydprice: Excited for this by our group ⁦@Daver_Leukemia⁩ ⁦@DrKTakahashi⁩ ⁦@doctorpemm⁩ ⁦@GBorthakur⁩ Frontiers | First Report of So…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.